2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 2464

Characterization of the Serum Anti-Citrullinated Protein Antibody Profile in Juvenile Idiopathic Arthritis: Association with Oral Health
Abstract Number: 2465

Cytokine Profile Comparison of Monogenic and Complex Conditions with Interferon-Regulated Gene Signatures in Chronic Atypical Neutrophilic Dermatosis with Lipodsytrophy and Elevated Temperature (CANDLE), SAVI, Aicardi-Goutieres Syndrome, JDM, and SLE
Abstract Number: 2466

Epigenetic Traits Correlate with Clinical Activity in Juvenile Idiopathic Arthritis
Abstract Number: 2467

Interaction Between Senescent T Cells and Fibrocyte-like Cells through CD31, TNFα, and IL-17 Create a Tissue Destructive Environment in the Synovium in Juvenile Idiopathic Arthritis
Abstract Number: 2468

Antibodies to Histocompatibility Antigens in Juvenile Systemic Lupus Erythematosus Patients
Abstract Number: 2469

The Lymphocyte Repertoire in Juvenile Dermatomyositis
Abstract Number: 2470

Single Center Experience in Next Generation Sequencing for Genetic Diagnosis of Autoinflammatory Disorders
Abstract Number: 2471

Increased Muscle Interferon-Gamma Expression Levels in Juvenile Dermatomyositis
Abstract Number: 2472

Highly Elevated S100A8/A9 and S100A12 Levels May Distinguish Systemic Juvenile Idiopathic Arthritis Patients with New Onset Disease and Subclinical Macrophage Activation Syndrome
Abstract Number: 2473

Psycho-Socio-Economic Burdens of Childhood Onset Rheumatic Diseases on Families
Abstract Number: 2474

Psychometric Properties of the Social Appearance Anxiety Scale in Patients with Limited and Diffuse Systemic Sclerosis: Analysis from the Scleroderma Patient-Centered Intervention Network Cohort
Abstract Number: 2475

Association Between Fibromyalgia and Suicidal Risk: A Systematic Review and Meta-Analysis
Abstract Number: 2476

Patient-Reported Cognitive Impairment, Pain, and Depressive Symptoms in Patients with Systemic Lupus Erythematosus and Comorbid Depression
Abstract Number: 2477

What Older Adults with Restricting Back Pain Worry about: Deteriorating Function, Reliance on Others, Distrust of Medications
Abstract Number: 2478

Does Affect Predict Willingness to Take Medication?

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].